Impact of PSA screening on mortality - PLCO Project Team (Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial)

被引:0
|
作者
Heidenreich, A. [1 ]
Nitschmann, S. [1 ]
机构
[1] Univ Klinikum RWTH Aachen, Klin & Poliklin Urol, D-51074 Aachen, Germany
来源
INTERNIST | 2010年 / 51卷 / 02期
关键词
D O I
10.1007/s00108-009-2571-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:219 / 220
页数:2
相关论文
共 50 条
  • [31] Measuring the impact of hipaxs privacy rule in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.
    Marcus, PM
    Miedzinksi, M
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (11) : S151 - S151
  • [32] Vitamin K intake and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial
    Hoyt, Margaret
    Reger, Michael
    Marley, Andrew
    Fan, Hao
    Liu, Ziyue
    Zhang, Jianjun
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2019, 109 (02): : 392 - 401
  • [33] Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial
    Prorok, Philip C.
    Wright, Patrick
    Riley, Thomas R.
    Kramer, Barnett S.
    Berg, Christine D.
    Gohagan, John K.
    [J]. REVIEWS ON RECENT CLINICAL TRIALS, 2018, 13 (04) : 257 - 273
  • [34] Positive biopsy (bx) rates for prostate cancer (PCA) based on prostate specific antigen (PSA) grouping in a large cancer screening trial: Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
    Reding, D.
    McCarty, C.
    Riley, T.
    Hickey, T.
    Hocking, W. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] PROSTATE CANCER DETECTION WITH DIGITAL RECTAL EXAM IN THE PROSTATE LUNG COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL
    Halpern, Joshua
    Shoag, Jonathan
    Mittel, Sameer
    Lipsitz, Stuart
    Ballman, Karla
    Hu, Jim
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E548 - E549
  • [36] Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Hayes, RB
    Reding, D
    Kopp, W
    Subar, AF
    Bhat, N
    Rothman, N
    Caporaso, N
    Ziegler, RG
    Johnson, CC
    Weissfeld, JL
    Hoover, RN
    Hartge, P
    Palace, C
    Gohagan, JK
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 349S - 355S
  • [37] Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Catherine A. McCarty
    Douglas J. Reding
    John Commins
    Craig Williams
    Meredith Yeager
    James K. Burmester
    Catherine Schairer
    Regina G. Ziegler
    [J]. Breast Cancer Research and Treatment, 2012, 133 : 785 - 792
  • [38] Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    McCarty, Catherine A.
    Reding, Douglas J.
    Commins, John
    Williams, Craig
    Yeager, Meredith
    Burmester, James K.
    Schairer, Catherine
    Ziegler, Regina G.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (02) : 785 - 792
  • [39] Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial
    Hocking, William G.
    Tammemagi, Martin C.
    Commins, John
    Oken, Martin M.
    Kvale, Paul A.
    Hu, Ping
    Ragard, Lawrence R.
    Riley, Tom L.
    Pinsky, Paul
    Beck, Thomas M.
    Prorok, Philip C.
    [J]. LUNG CANCER, 2013, 82 (02) : 238 - 244
  • [40] Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: Colorectal cancer survival by trial arm
    Doroudi, Maryam
    Pinsky, Paul F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)